SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin
16 references·1 citing·31 second hop
Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin (2001)Incremental cost-effectiveness ratio and …Bayesian cost‐effectiveness analysis from clinical trial data (2001)Bayesian cost‐effectiveness a…Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Definition, interpretation an…Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation (1999)Constructing confidence inter…Bayesian estimation of cost-effectiveness ratios from clinical trials (1999)Bayesian estimation of cost-e…A Bayesian approach to stochastic cost-effectiveness analysis (1999)A Bayesian approach to stocha…Uncertainty in Decision Models Analyzing Cost-Effectiveness (1998)Uncertainty in Decision Model…Net Health Benefits (1998)Net Health BenefitsConfidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Confidence intervals or surfa…Statistical Inference for Cost-Effectiveness Ratios (1997)Statistical Inference for Cos…ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)ESTIMATING CONFIDENCE INTERVA…Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem (1996)Confidence intervals for cost…Confidence intervals for cost/effectiveness ratios (1995)Confidence intervals for cost…In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)In Search of Power and Signif…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…The CE Plane (1990)The CE PlaneFoundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…Cost-effectiveness of adding atezolizumab to first-line chemotherapy in patients with advanced triple-negative breast cancer (2020)Cost-effectiveness of adding …How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Clinical decision analysis (2005)Methods for the Economic Evaluation of Health Care Programmes (2005)A Guide to Simulation (1983)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial (2004)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods (1997)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Assessing the costs of healthcare technologies in clinical trials. (1999)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods (2002)Non‐parametric methods for cost‐effectiveness analysis: the central limit theorem and the bootstrap compared (2009)Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra (2005)Measurement of health state utilities for economic appraisal (1986)Markov Models in Medical Decision Making (1993)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)
this work references cited by second hop

References

  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,136 cited
  • 1998Net Health Benefits1,104 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1990The CE Plane582 cited
  • 1994In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care404 cited
  • 1998Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane397 cited
  • 1996ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL313 cited
  • 2000Definition, interpretation and calculation of cost-effectiveness acceptability curves292 cited
  • 1999A Bayesian approach to stochastic cost-effectiveness analysis253 cited
  • 1996Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem189 cited
  • 1999Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation146 cited
  • 1995Confidence intervals for cost/effectiveness ratios131 cited
  • 1998Uncertainty in Decision Models Analyzing Cost-Effectiveness113 cited
  • 2001Bayesian cost‐effectiveness analysis from clinical trial data108 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1999
Bayesian estimation of cost-effectiveness ratios from clinical trials
95 cited
  • 1997Statistical Inference for Cost-Effectiveness Ratios91 cited
  • Cited by

    • 2020Cost-effectiveness of adding atezolizumab to first-line chemotherapy in patients with advanced triple-negative breast cancer52 cited